Profound Medical (PROF) Net Cash Flow (2024 - 2026)

Profound Medical's Net Cash Flow history runs 3 years deep, the most recent figure standing at -$8.6 million for Q1 2026.

• On a quarterly basis, Net Cash Flow changed 0.12% year-over-year to -$8.6 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 56.68% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 91.39% from the prior year.
• Net Cash Flow declined to -$8.6 million in Q1 2026 per PROF's latest filing, from $34.9 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $34.9 million in Q4 2025 and bottomed at -$13.7 million in Q2 2025.
• The 3-year median for Net Cash Flow is -$7.4 million (2024), against an average of $2.8 million.
• Biggest YoY gain for Net Cash Flow was 17.95% in 2025; the steepest drop was 153.83% in 2025.
• Year by year, Net Cash Flow stood at $29.6 million in 2024, then increased by 17.95% to $34.9 million in 2025, then slumped by 124.62% to -$8.6 million in 2026.
• Per Business Quant, the three latest PROF Net Cash Flow figures stand at -$8.6 million (Q1 2026), $34.9 million (Q4 2025), and -$9.6 million (Q3 2025).